Atlas Trials

Exact Sciences Corporation

31 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Exact Sciences Corporation

RecordFirmDate
Endometrial Cancer Vaginal Fluid Specimen Collection Study (NCT07544680)Exact Sciences Corporation2026-03-10
Falcon Real World Evidence Registry (NCT06589310)Exact Sciences Corporation2024-08-01
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) (NCT06401421)Exact Sciences Corporation2024-06-07
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer (NCT06398743)Exact Sciences Corporation2023-06-20
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer (NCT05210283)Exact Sciences Corporation2021-12-15
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01 (NCT04473625)Exact Sciences Corporation2020-07-21
Home Usability Study of the SARS-CoV-2 (COVID-19) Test (NCT04395391)Exact Sciences Corporation2020-05-18
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing (NCT04213326)Exact Sciences Corporation2019-11-18
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" (NCT04144738)Exact Sciences Corporation2019-11-15
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C" (NCT04144751)Exact Sciences Corporation2019-11-15
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality (NCT04124406)Exact Sciences Corporation2019-10-18
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma (NCT03727087)Exact Sciences Corporation2019-01-10
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold (NCT03821948)Exact Sciences Corporation2019-01-03
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast (NCT03789162)Exact Sciences Corporation2018-12-20
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies (NCT03727009)Exact Sciences Corporation2018-12-07
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC. (NCT03741166)Exact Sciences Corporation2018-11-08
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now (NCT03728348)Exact Sciences Corporation2018-11-06
Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01) (NCT03705013)Exact Sciences Corporation2018-10-30
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204)Exact Sciences Corporation2018-08-23
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma (NCT03628651)Exact Sciences Corporation2018-04-02

Track Exact Sciences Corporation automatically

Every clearance here is in the API, with alerts when new ones post.